Matthew Shapanka

Photo of Matthew Shapanka

Matthew Shapanka leverages his experience in government and politics to represent corporate, political, and individual clients in criminal, regulatory, and legislative matters before government agencies and Congress. He also advises companies, PACs, candidates, and nonprofits on compliance with federal and state campaign finance, election, and lobbying laws.

Latest Articles

The U.S. Patent and Trademark Office’s (“USPTO”) Office of the Chief Economist released a new report last week examining women inventor trends in the United States from 1976 to 2016.  The study showed that only 21 percent of U.S. patents granted during that 40-year period include at least one woman listed as an inventor.  Despite growing rates of women earning science, technology, engineering, and mathematics (“STEM”) degrees, and increasing participation rates among women in nearly…
Patents have been mainstay of the Judiciary Committee agenda in both chambers for more than a decade, but never before has the debate seemed so firmly focused on strengthening patent rights.  Significant patent bills are pending in both chambers, and the House and Senate Judiciary Committees have summoned Andrei Iancu, the new director of the U.S. Patent and Trademark Office (USPTO), to testify at oversight hearings early in his tenure at the agency.  Notably, unlike…
Change is afoot at the U.S. Patent and Trademark Office (USPTO).  Since Director Andrei Iancu took office in February and declared “creating a new pro-innovation, pro-IP dialogue” a top priority, the agency has experienced a flurry of activity.  Beyond the significant shift in its rhetoric on intellectual property, the USPTO has moved to “increase predictability of appropriately-scoped claims,” and has initiated a full review of the process governing the Patent Trial and Appeal Board (PTAB). …
While the din over a possible government shutdown dominated the headlines, political law played a supporting role in the recently enacted Consolidated Appropriations Act (Pub. L. No. 115-141).  The content and omissions of the so-called “Omnibus” spending bill will be of interest to political actors in all sectors, but particularly those operating nonprofit entities engaged in political activity.  The Act also continues to prohibit government agencies from requiring corporate political activity disclosure, including…